19.56

2.14% 0.41

After Hours: 19.56

Oculis Holding Ag (OCS)

Overview News Price History Discussions Forecast

Oculis Holding Ag stock is traded at $19.56, with a volume of 34,216. It is up +2.14% in the last 24 hours and up +5.33% over the past month. Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Previous Close:

$19.15

Open:

$19.34

24h Volume:

34,216

Relative Volume:

0.92

Market Cap:

$938.88M

Revenue:

Net Income/Loss:

$-75.28M

P/E Ratio:

-9.8011

EPS:

-1.9957

Net Cash Flow:

$-57.45M

1W Performance:

+0.31%

1M Performance:

+5.33%

6M Performance:

+25.79%

1Y Performance:

+63.68%

1-Day Range:

$19.16

$19.60

1-Week Range:

$19.00

$19.82

52-Week Range:

$10.79

$23.08

Oculis Holding Ag Stock (OCS) Company Profile

Name

Oculis Holding Ag

Sector

Healthcare (1168)

Industry

Biotechnology (661)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

OCS's Discussions on Twitter

Compare OCS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OCS Oculis Holding Ag	19.56	1.02B	0	-75.28M	-57.45M	-1.9957
ONC Beone Medicines Ltd Adr	257.00	26.69B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	443.82	114.81B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.282	41.83M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	85.54	6.60B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	483.07	65.36B	14.09B	4.50B	2.96B	39.28

Oculis Holding Ag Stock (OCS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-05-23	Initiated	Chardan Capital Markets	Buy
Oct-05-23	Initiated	Stifel	Buy
Jun-14-23	Initiated	BofA Securities	Buy
Jun-12-23	Initiated	H.C. Wainwright	Buy
Jun-08-23	Initiated	Robert W. Baird	Outperform
May-10-23	Initiated	Pareto	Buy
Apr-28-23	Initiated	Wedbush	Outperform

View All

Oculis Holding Ag Stock (OCS) Latest News

Jun 05, 2025

Oculis Holding AG Announces 2025 AGM Results and Strategic Approvals - TipRanks

Jun 05, 2025

Leerink Partners raises Oculis stock price target to $50 from $22 - Investing.com

Jun 05, 2025

Oculis Holding AG Reports Outcomes of 2025 Annual General Meeting and Shareholder Approvals - Nasdaq

Jun 05, 2025

Oculis Publishes Results of 2025 Annual General Meeting - The Manila Times

Jun 05, 2025

REG-Oculis Publishes Results of 2025 Annual General Meeting - TradingView

Jun 05, 2025

Jun 04, 2025

Citadel Advisors LLC Buys Shares of 22,911 Oculis Holding AG (NASDAQ:OCS) - Defense World

Jun 04, 2025

Jun 03, 2025

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - marketscreener.com

Jun 03, 2025

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewswire Inc.

Jun 03, 2025

Oculis to Participate in Upcoming June Investor Conferences - InvisionMag.com

Jun 03, 2025

Oculis Holding AG Announces Participation in Upcoming Investor Conferences in June 2025 - Nasdaq

Jun 03, 2025

May 27, 2025

Oculis (NASDAQ:OCS) Sees Large Volume Increase on Analyst Upgrade - Defense World

May 13, 2025

May 12, 2025

Oculis (NASDAQ:OCS) Price Target Raised to $33.00 - Defense World

May 12, 2025

May 10, 2025

Oculis Publishes Invitation to the Annual General Meeting - The Manila Times

May 10, 2025

May 09, 2025